Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations
- 20 February 2020
- journal article
- review article
- Published by Springer Nature in Nature Reviews Neurology
- Vol. 16 (3) , 154-170
Abstract
Neuromyelitis optica spectrum disorders (NMOSD) are a type of neurological autoimmune disease characterized by attacks of CNS inflammation that are often severe and predominantly affect the spinal cord and optic nerve. The majority of individuals with NMOSD are women, many of whom are of childbearing age. Although NMOSD are rare, several small retrospective studies and case reports have indicated that pregnancy can worsen disease activity and might contribute to disease onset. NMOSD disease activity seems to negatively affect pregnancy outcomes. Moreover, some of the current NMOSD treatments are known to pose risks to the developing fetus and only limited safety data are available for others. Here, we review published studies regarding the relationship between pregnancy outcomes and NMOSD disease activity. We also assess the risks associated with using disease-modifying therapies for NMOSD during the course of pregnancy and breastfeeding. On the basis of the available evidence, we offer recommendations regarding the use of these therapies in the course of pregnancy planning in individuals with NMOSD.Keywords
This publication has 188 references indexed in Scilit:
- Prenatal Glucocorticoid Treatment and Later Mental Health in Children and AdolescentsPLOS ONE, 2013
- Myasthenia gravis and neuromyelitis optica spectrum disorderNeurology, 2012
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsJournal of Neuroinflammation, 2012
- IgG Placental Transfer in Healthy and Pathological PregnanciesJournal of Immunology Research, 2011
- Corticosteroid use during pregnancy and risk of orofacial cleftsCanadian Medical Association Journal, 2011
- Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaBrain, 2008
- First trimester exposure to corticosteroids and oral cleftsBirth Defects Research Part A: Clinical and Molecular Teratology, 2003
- Mitoxantrone and etoposide in breast milkAmerican Journal of Hematology, 1995
- Prednisolone excretion in human milkThe Journal of Pediatrics, 1985
- Teratogenic effects of azathioprine (Imuran)The Journal of Pediatrics, 1965